|
Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure
RECRUITINGN/ASponsored by Montreal Heart Institute
Actively Recruiting
PhaseN/A
SponsorMontreal Heart Institute
Started2021-09-01
Est. completion2026-12-01
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04970888
Summary
The objective of this project is to assess the effects of combined physical exercise and cognitive training interventions on cognitive and brain health in patients with heart failure (HF). Also, the role of sex on the effects of the interventions will be assessed.
Eligibility
Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥ 50 years old * Stable chronic HF on maximally tolerated background treatment for at least 2 months (stable therapy with ACE-I, ARBs and MRA for at least 2 months), regardless of LVEF * with no limitation of physical activity in ordinary physical activity (i.e. NYHA class I), moderate symptoms (i.e. NYHA class II) or marked limitation in activity (i.e. NYHA class III) * Able to perform cognitive and physical training. Exclusion Criteria: * Acute cardiovascular event 1 month prior to randomization, including emergency visit or hospitalization for decompensated HF, acute myocardial infarction, stroke, and transient ischemic attack * Planned cardiovascular intervention within 6 months (implantation of any cardiac device, cardiac revascularization, heart transplantation) * Severe exercise intolerance * Contraindications for exercise testing (e.g., uncorrected severe aortic or carotid stenosis, severe pulmonary hypertension, severe non-revascularizable coronary disease including left main coronary stenosis, significant myocardial ischemia or arrhythmia during low-intensity exercise, acute HF) * Severe respiratory disease * Non-cardiopulmonary limitation to exercise (e.g., arthritis, claudication or any peripheral neurological disease including other neurodegenerative diseases such as disabling Parkinson) * Uncontrolled diabetes or untreated thyroid dysfunction * Current or recent malignancy with life expectancy \< 1 year * Chronic hemodialysis or peritoneal dialysis * Unable to read the informed consent form or unable to understand the oral explanations provided by the assessor.
Conditions3
AgingChronic Heart FailureHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMontreal Heart Institute
Started2021-09-01
Est. completion2026-12-01
Eligibility
Age50 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04970888